
|Articles|October 23, 2014 (Updated: November 15, 2020)
US Healthcare Reform: A Pharm Exec Digest Special
Author(s)The Pharm Exec staff
This month’s special issue of Pharm Exec Global Digest looks at..
Advertisement
This month’s special issue of Pharm Exec Global Digest looks at
- Dealing with the “side effects” of Obamacare
- The “value” of Rxs under Obamacare
- The escalating cost of US oncology care
- And more…
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Leading in the Psychedelic Space: Q&A with Tarek Rabah
3
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
4
Boehringer Ingelheim Acquires Exclusive License from Sitryx Therapeutics for Preclinical Small Molecule Program
5




